Dalong Cao

Fudan University Shanghai Cancer Center

Papers

1

Total Citations

3

H-Index

1

About

Dalong Cao is a pioneering urologic surgeon whose research centers on the clinical translation of novel robotic surgical platforms, with a specific focus on improving outcomes in prostate and renal surgeries. His most cited work, a 2025 study on the Carina robotic platform, represents a landmark contribution to the field, demonstrating the feasibility and safety of this modular system in 11 robot-assisted radical prostatectomies and 7 partial nephrectomies. This early clinical experience, already garnering 3 citations, positions Cao as a key evaluator of next-generation surgical technology, directly addressing the critical need for more adaptable and accessible robotic tools. His research not only validates the Carina platform’s potential to expand minimally invasive options but also provides essential safety data that will guide its broader adoption. By systematically assessing a new system’s performance in complex urologic procedures, Cao is helping to shape the future of robotic surgery, making his work highly relevant for students and researchers interested in surgical innovation, device translation, and the evolution of urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Early clinical experience with the Carina robotic platform in urologic surgery
3 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Fudan University Shanghai Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago